Pancreatic α‐cell mass in obesity-Reference-Cited by-同舟云学术

Pancreatic α‐cell mass in obesity

Published:2017-07-13 Issue:12 Volume:19 Page:1810-1813
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Ellenbroek Johanne H.¹,Töns Hendrica A. M.¹,Hanegraaf Maaike A. J.¹,Rabelink Ton J.¹,Engelse Marten A.¹,Carlotti Françoise¹,de Koning Eelco J. P.¹²^ORCID

Affiliation:

1. Department of Internal MedicineLeiden University Medical Centre Leiden The Netherlands

2. Hubrecht Institute Utrecht The Netherlands

Funder

Diabetes Cell Therapy Initiative consortium, including the Dutch Diabetes Research Foundation

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12997

Reference15 articles.

1. Pancreatic alpha cell mass in European subjects with type 2 diabetes

2. Plasma concentrations of glucagon during hyperglycemic clamp with or without somatostatin infusion in obese subjects

3. Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation

4. Pancreatic β-cell mass in European subjects with type 2 diabetes

5. Islet Concentration in the Head, Body, Tail and Uncinate Process of the Pancreas

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The human α cell in health and disease;Journal of Endocrinology;2023-04-28

2. The relationship between glucose and the liver-alpha cell axis – A systematic review;Frontiers in Endocrinology;2023-01-05

3. Diabetes Resolution at 10 Years After Biliopancreatic Diversion in Overweight and Class 1 Obese Patients with Type 2 Diabetes;Obesity Surgery;2022-01-10

4. Insulin action in subjects with type 2 diabetes following biliopancreatic diversion;European Journal of Clinical Investigation;2021-12-12

5. Mof acetyltransferase inhibition ameliorates glucose intolerance and islet dysfunction of type 2 diabetes via targeting pancreatic α-cells;Molecular and Cellular Endocrinology;2021-11